Quantitative detection of a cocktail of mycobacterial MPT64 and PstS1 in tuberculosis patients by real-time immuno-PCR
Abstract
Aim: There is an urgent need to design a reliable diagnostic test for tuberculosis (TB). Methods: Real-time immuno-PCR (RT-I-PCR) assay was devised for the quantitative detection of a cocktail of mycobacterial MPT64 (Rv1980c) and PstS1 (Rv0934) in TB patients. Results: A broad dynamic range of 0.95 pg/ml–95 ng/ml of MPT64+PstS1 was detected in TB patients. In smear-positive (n = 59) and smear-negative (n = 42) pulmonary TB cases, sensitivities of 93.2 and 83.3% were observed, respectively with 92.8% specificity, whereas a sensitivity of 77.9% and a specificity of 91.3% were observed in extrapulmonary TB cases (n = 86). Furthermore, significantly reduced MPT64+PstS1 concentrations (p < 0.001) were noticed in patients on therapy by RT-I-PCR as compared with untreated patients. Conclusion: Our RT-I-PCR assay revealed high sensitivity especially for the rapid diagnosis of smear-negative pulmonary TB and paucibacillary extrapulmonary TB samples, which could also monitor the dynamics of disease in patients on therapy.
Papers of special note have been highlighted as: • of interest; •• of considerable interest
References
- 1 WHO. Global tuberculosis control. WHO Report. WHO, Geneva (2018). www.who.int/tb/publications/global_report/en/.
- 2 . Diagnosis of extrapulmonary tuberculosis by PCR. FEMS Immunol. Med. Microbiol. 66(1), 20–36 (2012).
- 3 . Diagnosis of active tuberculosis disease: from microscopy to molecular techniques. J. Clin. Tuberc. Other Mycobact. Dis. 1(4), 33–43 (2016).
- 4 . Use of nucleic acid amplification tests in tuberculosis patients in California. Open Forum Infect. Dis. 3(4), ofw230 (2016).
- 5 . Diagnostic performance of Xpert MTB/RIF in tuberculous pleural effusion: systematic review and meta-analysis. J. Clin. Microbiol. 54(4), 1133–1136 (2016).
- 6 Comparative evaluation of GeneXpert MTB/RIF and multiplex PCR targeting mpb64 and IS6110 for the diagnosis of pleural tuberculosis. Future Microbiol. 13, 407–413 (2018). • Describes the comparative evaluation of Xpert assay and multiplex PCR (mpb64 and IS6110) for the diagnosis of tuberculosis (TB) pleuritis.
- 7 . Detection of potential microbial antigens by immuno-PCR (PCR-amplified immunoassay). J. Med. Microbiol. 63(5), 627–641 (2014). •• Presents a review for the detection of potential viral, bacterial and parasitic antigens by immuno-PCR (I-PCR) and emphasizes the superiority of I-PCR over analogous ELISA.
- 8 Immuno-PCR, a new technique for the serodiagnosis of tuberculosis. J. Microbiol. Methods 139, 218–229 (2017). • Presents a comprehensive review on the detection of Mycobacterium tuberculosis antigens and antibodies in bodily fluids of TB patients by I-PCR.
- 9 . Diagnosis of pulmonary and extrapulmonary tuberculosis based on detection of mycobacterial antigen 85B by immuno-PCR. Diagn. Microbiol. Infect. Dis. 83, 359–364 (2015). •• Details the detection of immunodominant Ag85B in TB patients by I-PCR.
- 10 . Tuberculosis diagnosis using immunodominant, secreted antigens of Mycobacterium tuberculosis. Tuberculosis (Edinb.) 93(4), 381–388 (2013).
- 11 Combinatorial use of antibodies to secreted mycobacterial proteins in a host immune system-independent test for tuberculosis. J. Clin. Microbiol. 39(7), 2418–2424 (2001).
- 12 . Development of an ultrasensitive polymerase chain reaction-amplified immunoassay based on mycobacterial RD antigens: implications for the serodiagnosis of tuberculosis. Diagn. Microbiol. Infect. Dis. 72(2), 166–174 (2012). •• Presents the detection of a cocktail of M. tuberculosis RD antigens, i.e. ESAT-6, CFP-21, etc. in bodily fluids of TB patients by I-PCR.
- 13 . Cloning and B-cell-epitope mapping of MPT64 from Mycobacterium tuberculosis H37Rv. Infect. Immun. 62(5), 2058–2064 (1994).
- 14 . Utility of MPT 64 antigen detection assay for rapid characterization of mycobacteria in a resource constrained setting. Indian J. Tuberc. 59(2), 92–96 (2012).
- 15 Rapid immunochromatographic assay for diagnosis of tuberculosis: antibodies detected may not be specific. J. Clin. Microbiol. 37(6), 2111–2112 (1999).
- 16 Detection of Mycobacterium tuberculosis GlcB or HspX Antigens or devR DNA impacts the rapid diagnosis of tuberculous meningitis in children. PLoS ONE 7, e44630 (2012).
- 17 Development of real-time immuno-PCR for the quantitative detection of mycobacterial PstS1 in tuberculosis patients. J. Microbiol. Methods 132, 134–138 (2017). • Describes the development of real-time-I-PCR to detect PstS1 protein in TB patients.
- 18 Serodiagnostic potential of immuno-PCR using a cocktail of mycobacterial antigen 85B, ESAT-6 and cord factor in tuberculosis patients. J. Microbiol. Methods 120, 56–64 (2016).
- 19 India TB Report 2018. Revised National TB Control Program. https://tbcindia.gov.in/showfile.php?lid=3314.
- 20 R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing, 2018 Vienna, Austria. www.R-project.org/.
- 21 . Detecting antigens by quantitative immuno-PCR. Nat. Protoc. 2(8), 1918–1930 (2007).
- 22 . Estimation of the role of the test GeneXpert MTB/RIF in the diagnosis of pulmonary tuberculosis. Eur. Respir. J. 44, P2677 (2014). • Details the utility of Xpert assay for the diagnosis of pulmonary TB cases.
- 23 Comparison of same day diagnostic tools, including GeneXpert and unstimulated IFN-γ for the evaluation of pleural tuberculosis: a prospective cohort study. BMC Pulm. Med. 14, 58 (2014).
- 24 . Histopathological and microbiological findings and diagnostic performance of GeneXpert in clinically suspected tuberculous lymphadenitis. Int. J. Infect. Dis. 76, 73–81 (2018). •• Describes the utility of Xpert assay for detecting TB lymphadenitis.
- 25 Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am. J. Respir. Crit. Care Med. 184(1), 132–140 (2011).
- 26 . Evaluation of the GeneXpert MTB/RIF assay for rapid diagnosis of tuberculosis and detection of rifampin resistance in pulmonary and exrapulmonary specimens. J. Clin. Microbiol. 49(12), 4138–4141 (2011).
- 27 . Heterogeneous antibody responses in tuberculosis. Infect. Immun. 66(8), 3936–3940 (1998).
- 28 Utility of a combination of RD1 and RD2 antigens as a diagnostic marker for tuberculosis. Diagn. Microbiol. Infect. Dis. 66(2), 153–161 (2010).
- 29 . Detecting respiratory syncytial virus using nanoparticle-amplified immuno-PCR. Methods Mol. Biol. 1026, 93–110 (2013).
- 30 . Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. Eur. Respir. J. 44(2), 435–446 (2014).
- 31 Xpert MTB/RIF ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study. Lancet Infect. Dis. 18(1), 76–84 (2018).
- 32 . Factors associated with humoral response to ESAT-6, 38kDa and 14kDa antigens in patients with a spectrum of tuberculosis. Int. J. Tuberc. Lung Dis. 7(5), 478–484 (2003).
- 33 Evaluation of the clinical value of ELISA based on MPT64 antibody aptamer for serological diagnosis of pulmonary tuberculosis. BMC Infect. Dis. 12, 96 (2012).
- 34 . Immunomagnetic quantitative immuno-PCR for detection of less than one HIV-1 virion. J. Virol. Methods 157(2), 122–132 (2009).